Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research

Rise in prevalence of rabies in developing countries, increase in number of dog bites and rising number of stray dogs and presence of large market players who manufactures rabies vaccine is anticipated to boost the growth of rabies vaccine market. Moreover, rise in awareness among the...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: PET MRR Source Type: news